600+ projects in BioPharma and MedTech From early-stage candidates to global brand leaders, we work with companies across every stage, sector, geography and disease area to position assets for maximum value and impact. With 600+ life science projects, Back Bay delivers a keen understanding of t...
Since our last industry report in 2022, increased competition, rapid advancements in treatment, increased biosimilar adoption, and pressure from payers are increasingly requiring biopharma companies to find innovative ways to mitigate risks and capture emerging opportunities. They must ...
“Compared with cities which were first movers in the biopharmaceutical sector, such as Beijing, Shanghai, Suzhou and Chengdu, Shenzhen is a late starter. But in terms of innovation, Shenzhen has surpassed these cities in certain areas. There are some highly innovative enterprises which are found...
Connecting companies with qualified talent in biopharmaceutical, medical device, diagnostics, bioinformatics and medical/high tech blended industries.
the Chinese government has establishedseven biomedical city clusters, spanning fromJing-Jin-Ji Area,the Yangtze River Delta, andGreater Bay Areato places in central andwestern China. These regions host industrial zones that incubate key research entities and companies that facilitates technical developmen...
October 17, 2024 · 2 min read · Angela Gabriel Infectious disease GSK, ViiV Tout 99% Effectiveness for Long-Acting HIV PrEP as Gilead Gains Ground October 17, 2024 · 2 min read · Tristan Manalac Vaccines Bavarian Nordic’s Jynneos Elicits ‘Robust’ Mpox Antibody Response in Adolescents...
Today, bioBay has more than 360 high-tech innovative companies with an estimated US$800 million registered capital in its 1,000,000 m2 campus and provides comprehensive services to the hosted companies (data from bioBay presentations). CRO industry is one of its five sectors, with companies ...
Warning about false stories on social media … it IS NOT a deliberate plot by the pharmaceutical companies to sell more vaccines! Dean: I gather MERS (Middle East Respiratory Syndrome) , SARS (Severe Acute Respiratory Syndrome) and this new virus are all coronaviruses – how similar are they...
Strategic Acquisitions With the continuous standardization of the medical device industry in China, the Group believes that the merger and acquisition of the medical device companies in respect of core business will be a future trend which will increase the industry concentration and thus enhancing the...
But the overall size of the workforce has not changed much in the past three years as additions in China have been countered by a shrinking field force elsewhere, reflecting a stronger focus on secondary rather than primary care. The ten largest companies now employ some 750,000 ...